Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 InterHealth's OptiBerry Shown to Inhibit Angiogenesis - Nutraceuticals World

What are you searching for?

Sign in
Research

InterHealth’s OptiBerry Shown to Inhibit Angiogenesis

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Recent studies published in peer reviewed journals have shown that OptiBerry™, a patent-pending, standardized multiple berry extract developed by InterHealth Nutraceuticals, possesses potent anti-angiogenic properties, which inhibit the growth of unwanted blood vessels involved in the formation of tumors and varicose veins. Researchers at The Ohio State University Medical Center, Columbus, OH, University of Kupio, Kupio, Finland and Creighton University Medical Center, Omaha, NE, have shown that OptiBerry significantly inhibits angiogenesis both in vitro and in vivo, thus offering potential benefit in the treatment of related disorders such as cancer and inflammation. The studies were published in Free Radical Research and the Federation of European Biochemical Societies (FEBS) Letters. OptiBerry contains numerous berry extracts, including wild blueberry, bilberry, cranberry, elderberry, raspberry and strawberry.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics